For the Inventor, By the Inventor

Enter assignee name

Bloomington, MN, United States of America

Healthpartners Research Foundation

USPTO Granted Patents = 30

CIPO Patents = 3

EPO Patents = 5

Forward Citations = 190

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

William Howard Frey, Ii (29 out of 56 patents)

Leah Ranae Bresin Hanson (15 out of 27 patents)

Samuel Scott Panter (11 out of 13 patents)

4. John Randall Fawcett (7 out of 7 patents)

5. David C Yeomans (4 out of 14 patents)

6. Daniel Jacobs (4 out of 26 patents)

7. Martin S Angst (4 out of 9 patents)

8. John D Hoekman (1 out of 21 patents)

9. Sergei M Gryaznov (1 out of 83 patents)

10. Shyeilla V Dhuria (1 out of 2 patents)

11. Leah R Hansom (1 out of 1 patent)

12. Jens Pohl (1 out of 23 patents)

13. Annina Roeytenberg (1 out of 2 patents)

14. Neil J Johnson (1 out of 1 patent)

15. George R Biltz (1 out of 1 patent)

30 patents: Sort by Forward Citations

1. 9808509 - Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system (2017-11-07),

2. 9801835 - Method of pre-treating patients for stroke comprising administering metal chelators to the upper one-third of the nasal cavity (2017-10-31),

3. 9636313 - Method of treating spinal cord injury comprising administering metal chelators to the upper one-third of the nasal cavity (2017-05-02),

4. 9636312 - Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavity (2017-05-02),

5. 9629819 - Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavity (2017-04-25),

6. 9480649 - Lipid microparticle growth factor formulations (2016-11-01),

7. 9345676 - Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity (2016-05-24),

8. 9216161 - Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity (2015-12-22),

9. 9211273 - Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity (2015-12-15),

10. 9211272 - Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavity (2015-12-15),

11. 9205066 - Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity (2015-12-08),

12. 9072756 - Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog (2015-07-07),

13. 8772263 - Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions (2014-07-08),

14. 8771681 - Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection (2014-07-08),

15. 8765711 - Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage (2014-07-01),

HealthPartners Research Foundation (HPRF) is a non-profit organization dedicated to conducting innovative and impactful research in healthcare. HPRF collaborates with health systems, academic institutions, and industry partners to advance knowledge and improve patient outcomes. With a multidisciplinary team of scientists and clinicians, HPRF focuses on a wide range of research areas, including population health, clinical effectiveness, health disparities, and healthcare innovations. Through their research, HPRF aims to drive evidence-based practices and contribute to the development of solutions that address the complex challenges in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

30 Patents

#10 in Bloomington, MN

#313 in Minnesota

#10,872 in US

#21,209 in the World

Bloomington, MN, United States of America

Healthpartners Research Foundation

Forward Citations = 190

25 inventors:

William Howard Frey, Ii (29 out of 56 patents)

Leah Ranae Bresin Hanson (15 out of 27 patents)

Samuel Scott Panter (11 out of 13 patents)

4. John Randall Fawcett (7 out of 7 patents)

5. David C Yeomans (4 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…